Teleflex Incorporated (NYSE:TFX) Shares Purchased by International Assets Investment Management LLC

International Assets Investment Management LLC raised its stake in Teleflex Incorporated (NYSE:TFX) by 29,127.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,215 shares of the medical technology company’s stock after acquiring an additional 3,204 shares during the quarter. International Assets Investment Management LLC’s holdings in Teleflex were worth $795,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Sequoia Financial Advisors LLC increased its position in shares of Teleflex by 2.4% during the third quarter. Sequoia Financial Advisors LLC now owns 6,637 shares of the medical technology company’s stock worth $1,641,000 after purchasing an additional 153 shares in the last quarter. Allspring Global Investments Holdings LLC increased its position in shares of Teleflex by 41.5% during the third quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company’s stock worth $6,010,000 after purchasing an additional 7,132 shares in the last quarter. Cadent Capital Advisors LLC increased its position in shares of Teleflex by 23.4% during the third quarter. Cadent Capital Advisors LLC now owns 1,674 shares of the medical technology company’s stock worth $414,000 after purchasing an additional 317 shares in the last quarter. Blue Trust Inc. increased its position in shares of Teleflex by 47.2% during the third quarter. Blue Trust Inc. now owns 312 shares of the medical technology company’s stock worth $77,000 after purchasing an additional 100 shares in the last quarter. Finally, Net Worth Advisory Group purchased a new stake in shares of Teleflex during the third quarter worth approximately $297,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $238.93, for a total value of $638,898.82. Following the sale, the director now directly owns 5,496 shares in the company, valued at $1,313,159.28. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.43% of the company’s stock.

Teleflex Trading Down 1.8 %

TFX opened at $203.50 on Wednesday. Teleflex Incorporated has a 52 week low of $195.51 and a 52 week high of $257.85. The business has a fifty day simple moving average of $238.09 and a 200-day simple moving average of $224.11. The firm has a market cap of $9.45 billion, a P/E ratio of 40.46, a P/E/G ratio of 1.92 and a beta of 1.18. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping the consensus estimate of $3.38 by $0.11. The business had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company’s quarterly revenue was up 2.4% on a year-over-year basis. During the same period last year, the business posted $3.64 earnings per share. On average, equities analysts expect that Teleflex Incorporated will post 13.97 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex’s payout ratio is currently 27.04%.

Analysts Set New Price Targets

Several brokerages recently commented on TFX. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. Mizuho dropped their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Stephens upped their target price on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a report on Friday, August 2nd. Truist Financial restated a “hold” rating and issued a $227.00 target price (down from $255.00) on shares of Teleflex in a report on Monday. Finally, Royal Bank of Canada cut their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $259.25.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.